ARTICLE | Company News
Profectus, U.S. Department of Health and Human Services infectious news
December 8, 2014 8:00 AM UTC
HHS’s Biomedical Advanced Research and Development Authority (BARDA) awarded Profectus $5.8 million under a one-year contract to fund IND-enabling toxicology studies of VesiculoVax Ebola vaccine and t...